Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: a multicenter, randomized, double-blind, placebo-controlled trial.

MLA

Lewin AJ, et al. “Effects of Simvastatin on the Lipid Profile and Attainment of Low-Density Lipoprotein Cholesterol Goals When Added to Thiazolidinedione Therapy in Patients with Type 2 Diabetes Mellitus: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.” Clinical Therapeutics, vol. 26, no. 3, Mar. 2004, pp. 379–89. EBSCOhost, https://doi.org/10.1016/s0149-2918(04)90033-1.

APA

Lewin AJ, Kipnes MS, Meneghini LF, Plotkin DJ, Perevozskaya IT, Shah S, Maccubbin DL, Mitchel YB, Tobert JA, & Simvastatin/Thiazolidinedione Study Group. (2004). Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: a multicenter, randomized, double-blind, placebo-controlled trial. Clinical Therapeutics, 26(3), 379–389. https://doi.org/10.1016/s0149-2918(04)90033-1

Chicago

Lewin AJ, Kipnes MS, Meneghini LF, Plotkin DJ, Perevozskaya IT, Shah S, Maccubbin DL, Mitchel YB, Tobert JA, and Simvastatin/Thiazolidinedione Study Group. 2004. “Effects of Simvastatin on the Lipid Profile and Attainment of Low-Density Lipoprotein Cholesterol Goals When Added to Thiazolidinedione Therapy in Patients with Type 2 Diabetes Mellitus: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.” Clinical Therapeutics 26 (3): 379–89. doi:10.1016/s0149-2918(04)90033-1.